SLC25A13 and hepatocellular carcinoma: In particular, we have shown that FOXA2 works as a transcriptional activator and this might be a possible mechanism responsible for SLC25A13 high expression levels in liver and downregulation in HCC as well as its expression pattern in different tissues.